Stefanie Altmann, DO
Internal Medicine · Walnut Creek, CANPI 1912494188
Payments from drug & device makers
Across 167 payments — averaging $36.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$810
- Lilly USA, LLC$787
- UCB, Inc.$516
- Sanofi$476
- Kerecis Limited$465
- Johnson & Johnson$392
- plus $3K from 24 others
What the payments were for
- Food & beverage$5,60291%
- Education$5299%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 38 | $810 |
| Lilly USA, LLC | 23 | $787 |
| UCB, Inc. | 10 | $516 |
| Sanofi | 11 | $476 |
| Kerecis Limited | 8 | $465 |
| Johnson & Johnson | 6 | $392 |
| Sun Pharmaceutical Industries Inc. | 9 | $346 |
| Janssen Scientific Affairs, LLC | 3 | $324 |
| Novartis | 10 | $306 |
| Incyte Corporation | 7 | $300 |
| Regeneron Healthcare Solutions, Inc. | 4 | $184 |
| Sanofi-aventis U.S. LLC | 2 | $179 |
| Galderma Laboratories, L.p. | 2 | $149 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 5 | $139 |
| Genentech USA, Inc. | 1 | $128 |
| Arcutis Biotherapeutics, Inc. | 2 | $112 |
| Boehringer Ingelheim | 3 | $78 |
| Almirall LLC | 4 | $70 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $67 |
| Surgenex LLC | 2 | $46 |
| E.r. Squibb & Sons, L.L.C. | 2 | $43 |
| Convatec Inc. | 2 | $35 |
| Amgen | 2 | $35 |
| Smith+Nephew | 1 | $27 |
| Blueprint Medicines Corporation | 1 | $24 |
| Verrica Pharmaceuticals Inc. | 1 | $21 |
| Biofrontera Inc. | 1 | $19 |
| Dermira, Inc. | 1 | $19 |
| Organon | 4 | $17 |
| VYNE Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 Marigen$1,041
- Tremfya$386
- DUPIXENT$351
- Kerecis Omega3 SurgiClose$347
- Kerecis Omega3 GraftGuide$347
- Cimzia$239
- TALTZ$229
- TWYNEO$134
- Erivedge$128
- OPZELURA$126
- Rinvoq$122
- COSENTYX$113
- LIBTAYO$110
- ILUMYA$100
How this compares
$6,131 in reported general payments places this provider in the 90th percentile of 13,581 internal medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 143 | $4,432 |
| Mupirocin | 264 | $1,980 |
| Clobetasol Propionate | 49 | $1,857 |
| Fluorouracil | 37 | $1,811 |
| Ketoconazole | 81 | $1,310 |
| Doxycycline Hyclate | 113 | $1,180 |
| Triamcinolone Acetonide | 150 | $1,091 |
| Doxycycline Monohydrate | 55 | $742 |
| Fluocinonide | 15 | $496 |
| Ciclopirox | 12 | $494 |
| Clindamycin Phosphate | 11 | $333 |
| Cephalexin | 51 | $327 |
| Hydrocortisone | 43 | $234 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $62 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Walnut Creek
- Helen StaceyWalnut Creek$20.4M
- Andrew ChengSouth San Francisco$55.1M
- Joel NeutelTustin$34.9M
- Donald BrandonSan Diego$34M
- William TownerLos Angeles$27.4M
- Rahul AggarwalSan Francisco$24M
- Masoud AzizadNorthridge$21.1M
- Rohit Loombala Jolla$15.1M
- Zeid KayaliColton$14.2M
- Alexandra DrakakiSanta Monica$14.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.